about
Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptorsRole of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsAnnexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway.Histone deacetylase inhibitors in the treatment of hematological malignancies.The Pharmaceutical Device Prisma® Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound HealingBenzodiazepine Scaffold as Drug-like Molecular Simplification of FR235222: A Chemical Tool for Exploring HDAC Inhibition.Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.Role of Annexin A1 in mouse myoblast cell differentiation.Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts.Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing.miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome EditingAnnexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model SystemTFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism
P50
Q28512121-9651CF80-F4F8-4C9E-8E2C-2215613A4E3FQ35522087-E19DD4CD-42DD-43B7-B68D-8E1C82A31A52Q37093146-BC1C254C-E46A-456B-A067-7B1F9E2205DFQ37874311-813C4107-78A5-4D3E-91B6-C6F8F88DB7E3Q38652718-D5C87463-6FD7-4B43-9385-29FAD1A55B75Q38750269-F5076F80-E725-4F60-BA88-A84E7F495F98Q38840434-CC48F25D-1AC9-491A-AD43-A75211F4B637Q39688368-69D36649-71BA-4A7C-87A2-8C81957A5FFEQ41718159-1441FDEB-7151-4758-A4CE-6265A3C7E8F9Q43283331-2E5B7C47-4F56-4404-89BF-B152222B71C2Q47810610-5E62D127-379E-464A-9DE1-16622B27CB94Q53381140-8E6E74B3-08D4-4F37-9E31-52D13B5D674CQ57595606-3070AD39-214A-4AFA-AD0B-B13E48F9F3E8Q60919625-8C01634D-889E-4EA4-9509-D46F356EF1D5Q89575253-56FEB426-6E81-4748-B69C-62B2D4B68077
P50
description
researcher ORCID ID = 0000-0002-5222-0705
@en
wetenschapper
@nl
name
Valentina Bizzarro
@ast
Valentina Bizzarro
@en
Valentina Bizzarro
@es
Valentina Bizzarro
@nl
type
label
Valentina Bizzarro
@ast
Valentina Bizzarro
@en
Valentina Bizzarro
@es
Valentina Bizzarro
@nl
prefLabel
Valentina Bizzarro
@ast
Valentina Bizzarro
@en
Valentina Bizzarro
@es
Valentina Bizzarro
@nl
P106
P1153
36170406000
P31
P496
0000-0002-5222-0705